Reduction in coronary events during treatment with pravastatin
- 28 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (9), 60C-63C
- https://doi.org/10.1016/s0002-9149(99)80472-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- Cholesterol reduction and its impact on coronary artery disease and total mortalityThe American Journal of Cardiology, 1995
- Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)The American Journal of Cardiology, 1995
- Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.Circulation, 1994
- Pravastatin, lipids, and major coronary eventsThe American Journal of Cardiology, 1994
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)The American Journal of Cardiology, 1993
- Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysisHeart, 1993
- Pravastatin, lipids, and atherosclerosis in the carotid arteries: Design features of a clinical trial with carotid atherosclerosis outcomeControlled Clinical Trials, 1992
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990